Vitamins: Absorption, Metabolism and Bioavailability

A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Natural and Synthetic Antioxidants".

Deadline for manuscript submissions: 1 June 2024 | Viewed by 202

Special Issue Editor


E-Mail Website
Guest Editor
Clinical Biochemistry and Molecular Biology, Faculty of Medicine, Department of Experimental Medicine, University Hospital of Tor Vergata (PTV), University of Rome Tor Vergata, Rome, Italy
Interests: clinical biochemistry; COVID; nutrition; vitamins; inflammation; neuroscience; neurodegenerative diseases; CSF indexes; blood morphology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Lifestyles and dietary regimens have been demonstrated to have positive effects on health. In particular, the appropriate application and combination of nutraceuticals (micronutrients, minerals, hormones and vitamins) are able to modulate the inflammatory response by preventing the development and progression of various pathologies, as well as those that affect the nervous system.

Prolonged deficiencies or the dysregulation of both water-soluble vitamins (such as B1, B2, B3, B5, B6, B7, B9, B12 and vitamin C) and fat-soluble vitamins (such as A,D,E.K) can participate in neurodegeneration in Alzheimer’s disease (AD), Parkinson’s disease (PD), Multiple Sclerosis (MS), Huntington’s disease (HD) and Amyotrophic lateral sclerosis (ALS).

In most of these neurodegenerative diseases, including PD and AD, neuroinflammation and oxidative stress primarily promote the death of neurons.

Vitamin A exhibits potent antioxidant activity and controls neural cell differentiation, vitamin C minimizes oxidative stress, and vitamin D inhibits neuroinflammation and protects dopaminergic neurons in PD. In AD and PD, vitamins of the B group regulate homocysteine, thus ​​protecting against neurodegeneration. In PD and AD, vitamins prevent, respectively, the oligomerization of alpha-synuclein and Aβ plaque formation. In MS, both vitamin A and vitamin D exhibit specific mechanisms, and anti-inflammatory and antioxidative activities.

Future studies and human clinical trials are required in order more comprehensively elucidate the efficacy and the protective role of vitamins in neurodegenerative diseases.

This Special Issue delves into the absorption, metabolism, and bioavailability of vitamins, exploring how these factors influence their efficacy in combating inflammation. Additionally, the Special Issue highlights the specific relevance of water- and fat-soluble vitamins in neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. Neurodegenerative diseases are characterized by chronic inflammation and oxidative stress, and emerging evidence suggests that vitamins may offer protective effects against neuroinflammation and neuronal damage.

By examining the intricate relationship between vitamins, inflammation, and neurodegenerative diseases, this Special Issue aims to provide a comprehensive understanding of the potential benefits of vitamin supplementation in the prevention and treatment of these debilitating conditions. The collection of research articles and reviews presented in this Special Issue will contribute to advancing knowledge in this field and may guide future research and clinical practices.

Dr. Maria Morello
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vitamins
  • absorption
  • metabolism
  • bioavailability
  • inflammation
  • neurodegenerative diseases
  • Parkinson's disease
  • Alzheimer's disease
  • multiple sclerosis
  • Huntington disease
  • amyotrophic lateral sclerosis
  • therapeutic interventions

Published Papers

This special issue is now open for submission.
Back to TopTop